O+ leuko-reduced ACD packed red blood cells

Ended Purchase Order Awarded Last action

Contract number
75N93025P00122
Awardee
Awarding agency
Obligated
$14,994

Award facts

Contract value 100% obligated
$14,994.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Los Angeles, CA 90032, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the provision of O+ leuko-reduced ACD packed red blood cells to the National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services. The $14,994.00 firm-fixed-price purchase order was awarded to Grifols Bio Supplies Inc., a for-profit organization, on November 25, 2024. The contract has an ultimate completion date of June 30, 2025 and does not utilize any set-aside designations. The contract supports the agency's medical research and healthcare operations by delivering the specified blood products to the agency's facility in Los Angeles, California.

Quick answers

Who was awarded contract 75N93025P00122?

75N93025P00122 was awarded to Grifols Bio Supplies Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 25, 2024.

How much is contract 75N93025P00122 worth?

The government has obligated $14,994 on 75N93025P00122.

Was contract 75N93025P00122 competed?

The extent of competition for 75N93025P00122 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award